You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Dow
Johnson and Johnson
AstraZeneca
McKesson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

OXAZEPAM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Oxazepam patents expire, and when can generic versions of Oxazepam launch?

Oxazepam is a drug marketed by Actavis Elizabeth, Am Therap, Frontida Biopharm, Ivax Sub Teva Pharms, Mylan, Sandoz, Watson Labs, Watson Labs Teva, Parke Davis, and Sun Pharm Industries. and is included in twenty NDAs.

The generic ingredient in OXAZEPAM is oxazepam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxazepam profile page.

US ANDA Litigation and Generic Entry Outlook for Oxazepam

A generic version of OXAZEPAM was approved as oxazepam by FRONTIDA BIOPHARM on August 10th, 1987.

  Start Trial

Drug patent expirations by year for OXAZEPAM
Drug Prices for OXAZEPAM

See drug prices for OXAZEPAM

Recent Clinical Trials for OXAZEPAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)Phase 1
Embera NeuroTherapeutics, Inc.Phase 1
National Institute on Drug Abuse (NIDA)Phase 0

See all OXAZEPAM clinical trials

Pharmacology for OXAZEPAM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for OXAZEPAM
Paragraph IV (Patent) Challenges for OXAZEPAM
Tradename Dosage Ingredient NDA Submissiondate
SERAX TABLET;ORAL oxazepam 015539
SERAX CAPSULE;ORAL oxazepam 015539

US Patents and Regulatory Information for OXAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth OXAZEPAM oxazepam CAPSULE;ORAL 072253-002 Apr 14, 1988 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz OXAZEPAM oxazepam CAPSULE;ORAL 071814-001 Apr 19, 1988 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs OXAZEPAM oxazepam TABLET;ORAL 071494-001 Apr 21, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Frontida Biopharm OXAZEPAM oxazepam CAPSULE;ORAL 071026-002 Aug 10, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
Am Therap OXAZEPAM oxazepam CAPSULE;ORAL 071955-001 Mar 3, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms OXAZEPAM oxazepam CAPSULE;ORAL 070945-001 Aug 3, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Boehringer Ingelheim
AstraZeneca
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.